• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Cytomegalic Inclusion Disease

Cytomegalic Inclusion Disease - 21 Studies Found

Completed : Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients
: Cytomegalovirus Disease
: 2009-01-23
:
  • Drug: Certican (everolimus) + valganciclovir

Completed : Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection
: Cytomegalovirus Disease
: 2012-01-10
:
  • Drug: Valganciclovir Valcyte p

Completed : A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients
: Cytomegalovirus Infections
: 2012-12-17
:
  • Drug: MCMV3068A Four doses of

Terminated : SUSTAIN: A Randomized, Double-Blind, Multicenter, Phase 3 Study of the Efficacy, Safety, and Tolerability of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease in CMV Seronegative Kidney Allograft Recipients
: Cytomegalovirus Disease
: 2015-05-07
:
  • Drug: Brincidofovir Other Name

Completed : Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients
: Cytomegalovirus Infection
: 2008-10-15
Completed : Evaluation of the PK and PD of Ganciclovir in Premature Infants Receiving Treatment for CMV Infection
: Cytomegalovirus Infections
: 2012-05-17
Completed : Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection
: Cytomegalovirus Infection
: 2009-04-14
:
  • Drug: HCMV-specific hyperimmune globulin (Cytotect®)

Active, not recruiting : A French Cohort of Transplant Recipients With CMV Infection : Risk Factors for Antiviral Resistance in the Prophylaxis Era.
: Transplant Recipients With CMV Infection
: 2014-02-14
: Biological: CMV Infection Routine follow-up (viral load, creatininaemia, neutrophil count, isolation of
Completed : gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent Females
: Cytomegalovirus Infections
: 2005-08-19
:
  • Biological: MF-59 Microfluorid

Completed : Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
: Cytomegalovirus Infections
: 2012-06-01
: Drug: Maribavir Tablet for oral administration
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.